Introduction
Cardiac fibrosis is a major feature of the pathological response of the diseased heart. It leads to global heart dysfunction and thus contributes to heart failure (HF) progression. Pro-fibrotic mechanisms are characterized by excessive collagen deposition, including an increase in collagen I and III expression and synthesis. 1 Cardiac fibroblasts of intra-cardiac origin are considered to be the major cellular mediators of these structural changes 1 and are mainly responsible for cardiac fibrosis development. 2, 3 Sex differences in cardiac fibrosis in patients with aortic stenosis (AS), hypertension, and arteriosclerosis have been reported. [4] [5] [6] [7] [8] [9] We showed previously that men with AS exhibit significant higher degree of cardiac fibrosis associated with stronger up-regulation of collagen I and III compared with women. 5, 6, 10 In line with clinical data, a mouse model with pressure overload induced myocardial hypertrophy (MH) by transverse aortic constriction (TAC) showed that male mice exhibit significant more cardiac fibrosis and pro-fibrotic gene expression compared with females. 11, 12 The underlying molecular mechanisms of observed sex differences are multifactorial and not fully understood. 13 Evidence points to the contribution of the sex steroid hormone 17b-Estradiol (E2). As for example, E2-supplemented ovariectomized (OVX) rodents showed less cardiac fibrosis after TAC and myocardial infarction compared with their respective controls without E2-treatment. [14] [15] [16] In the clinic, large-scale clinical trials on hormone replacement therapies revealed conflicting data about the E2-effect on the heart in women. 17, 18 In men with HF, abnormally low and high E2-levels are a significant predictor of poor prognosis and higher mortality. 19 This demonstrates the complexity of the cardiac E2-actions and points to the crucial importance to clarify the cardiac effects and mechanisms of E2 in more detail in both sexes. E2 predominantly mediates its effects via estrogen receptor alpha (ERa) and beta (ERb). Recent studies showed that ERa and ERb impact the development of cardiac fibrosis in mice of both sexes. 11, 15, 20, 21 We recently demonstrated that the ERa-agonist 16a-LE2 inhibits cardiac fibrosis after TAC in OVX mice. 15 In addition, ERb deletion in female mice led to an increase in cardiac fibrosis compared with female WT mice, whereas male mice with an ERb deficiency showed significantly less fibrosis compared with WT male mice after TAC. 11 Thus, both ER contribute to the sex-specific development of cardiac fibrosis. In order to therapeutically mimic or block E2 and ER mediated effects on cardiac fibrosis in both sexes, studies which identify the involved cardiac cell type and clarify the underlying mechanisms of E2 and ER action are necessary.
In previous investigations, we analysed the effect of E2 on pro-fibrotic genes in rat cardiac fibroblasts (rCF) isolated from male and female animals. We showed that E2 inhibits matrix metalloproteinase-2 (MMP-2) expression 22 and found that E2 significantly decreased collagen I and III in female rCF, but significantly increased collagen I and III expression in male cells. 5 However, the underlying mechanisms of E2-mediated sexspecific gene transcription regulation have not been clarified in detail. We, therefore, aimed to define the role of E2 and ER on sex-specific collagen I and III expression in primary rCF and human CF (hCF) from both sexes. We analysed whether E2-mediated sex-specific collagen I and III regulation is caused by sex-dimorphic ER-activation leading to a divergent ER down-stream signaling. The better understanding of sexdimorphic E2-signaling may pave the way to develop novel sex-specific strategies to counter cardiac fibrosis.
Methods

Cell culture
CF isolation from 9 to 11-week-old female and male Wistar rats, cultivation and E2-treatment was carried out as previously described. 22 hCF were obtained by the outgrowth from heart biopsies (left ventricular septum or atrium) from patients with AS. For more details on CF isolation, cultivation and E2-treatment, see Supplementary material online.
Engineered connective tissue
Engineered connective tissue (ECT) were derived from rCF of both sexes in the second passage as previously described. 23 For more details on ECT preparation, measurement, re-isolation of rCF from ECT, cell count, and FACS, see Supplementary material online.
Quantitative real-time polymerase chain reaction
Total RNA extraction and quantitative real-time polymerase chain reaction (qPCR) were performed as previously described. 22 mRNA content of target genes was normalized to the expression of hypoxanthineguanine phosphoribosyltransferase (HPRT) in cardiac fibroblasts and ribosomal protein L10 (RPL0) in mouse heart tissue. Primer sequences are listed in the Supplementary material online, Table S1 .
Western blot
Cell extract was isolated using modified RIPA buffer and separated by SDS-polyacrylamide gel electrophoresis as recently described. 22 Antibodies used are listed in the Supplementary material online.
Chromatin immunoprecipitation assays (ChIP)
Analyses were carried out to analyse ER-binding to putative ERE within the rat collagen I (Col1A1) and collagen III (Col3A1) gene promoter as revealed by database searches using MatInspector (www. 
Animal experiments
Experiments were performed in accordance with the guidelines of Charité-Universitaetsmedizin Berlin, approved by the Landesamt für Gesundheit und Soziales (LaGeSo, Berlin, Germany, G0027/11), and followed the 'Principles of Laboratory Animal Care' (NIH Publication No. 85-23, revised 2011). Mice were anaesthetized with Ketamine Hydrochloride (80 mg/ml)/Xylazine Hydrochloride (12 mg/mL) solution administered by intraperitoneal injection (1 mg/kg). The animals were treated with Rimadyl (5 mg/kg) for analgesia up to 7 days post-surgery. After 4 weeks of TAC, mice were anaesthetized with isoflurane (1.5%) and killed by cervical dislocation. For further details regarding OVX and TAC surgery, see Supplementary material online.
Data analysis and statistics
Results are expressed as mean ± standard error of the mean (SEM) from at least three independent experiments carried out in independent duplicates or triplicates. Significant differences were assessed by unpaired Mann-Whitney U-test, one-way ANOVA followed by Dunn's or Tukey's multiple comparison test as appropriate, using GraphPad Prism 7.01 software. P-values of < _0.05 were considered statistically significant.
Results
E2 mediates sex-specific collagen I and III regulation in hCF
We recently demonstrated on RNA level, that collagen I and III expression underlies a sex-dimorphic regulation in response to E2-treatment in rCF. 5 In line with these data, we showed that E2-treatment significantly down-regulated collagen I and III mRNA in hCF isolated from women ( Figure 1A) , whereas both collagen mRNA levels were up-regulated in response to E2 in male hCF ( Figure 1B ).
3.2
Collagen I and III protein levels are regulated in a sex-specific manner by 17b-Estradiol in rCF
Further, we confirmed that the observed E2-mediated sex-specific collagen I and III mRNA regulation 5 led to sex differences in collagen type I and III protein abundance in rCF ( Figure 2) . After 24 h E2-treatment, collagen I and III protein levels were significantly down-regulated in female rCF (Figure 2A ), whereas collagen I and III protein was increased in male rCF ( Figure 2B ). To ensure that the differences in collagen I and III expression are not simply a result of a difference in cell number, we performed a proliferation analysis. Female rCF proliferated slightly faster; however, neither in female nor in male rCF did E2-treatment have any influence on cell number after 24 h compared with vehicle groups (Supplementary material online, Figure S1 ).
ERa mediates collagen I and III downregulation in female rCF and ERb upregulates collagen I and III in male rCF
To investigate the underlying mechanisms of the E2-induced sex-specific collagen I and III regulation in female and male rCF in more detail, we first addressed the question of which ER subtype is involved. Therefore, cells of both sexes were treated with specific ERa-and ERb-agonists and compared with cells treated with E2 and vehicle for 24 h (Figure 3) . In female rCF, similar to E2, ERa-agonist treatment led to a significant downregulation of collagen I and III mRNA levels ( Figure 3A) , whereas the ERb-agonist had no effect. In contrast, similar to E2-treatment, the ERbagonist significantly increased collagen I and III mRNA level expression in male rCF ( Figure 3B) . The ERa-agonist showed no effect in male rCF.
ERa and ERb expression differ in female and male rCF
Differences in ER protein levels between female and male rCF could be one possible explanation for sex-specific ER activation by ER agonists. Therefore, we measured ERa and ERb protein levels in rCF ( Figure 4A) . Under basal conditions, we found no sex differences for the ERa level, whereas the ERb level was significantly higher in female compared with male rCF. A 24 h E2-treatment led to a significant down-regulation of ERa in female rCF and an up-regulation in male rCF ( Figure 4B ). In contrast, E2 had no effect on ERb expression.
ERa and ERb phosphorylation in response to E2 differ in female and male rCF
The activities of ERa and ERb are not only dependent on their expression levels, but also on post-translational modifications by Mean ± SEM from five to six independent samples derived from three independently repeated experiments; **P < _ 0.01, *P < _ 0.05, comparison was performed using Mann-Whitney U-test. phosphorylation. Serine 118 phosphorylation of ERa (P-Ser118-ERa) and serine 105 phosphorylation of ERb (P-Ser105-ERb) had been demonstrated to be essential for nuclear translocation and transcriptional activation upon E2-treatment. 24, 25 Interestingly, our data show that E2
significantly increased P-Ser118-ERa exclusively in female rCF and PSer105-ERb only in male rCF ( Figure 4C ), suggesting that E2-treatment leads to a sex-specific activation of ER signaling in rCF.
ERa and ERb binding to collagen I and III promoters is sex-specifically regulated
We further tested whether sex-specific E2-mediated ER activation leads to sex-dimorphic binding of ERa and ERb to the rat collagen I and III gene promoters. In female rCF, E2 significantly induced the binding of ERa and ERb to two putative ERE (Col1A1-ERE1: -957 bp to -952 bp and Col1A1-ERE2: -415 bp to -400 bp; relative to the translational start site) within the rat collagen I gene promoter ( Figure 5A and B). In male cells, only ERb bound to both putative ERE after E2-treatment ( Figure 5C ). Similarly, analysis of the collagen III gene promoter showed significant binding of ERa and ERb to two putative ERE (Col3A1-ERE1:
-648 bp to -644 bp and Col3A1-ERE2: -369 bp to -355 bp; relative to the translational start site) after E2-treatment in female rCF ( Figure 5D and E). In contrast, only ERb bound to both ERE upon E2-treatment in male cells ( Figure 5F ).
E2 mediates sex differences in threedimensional engineered connective tissue properties
We next analysed whether E2-mediated sex-specific collagen I and III regulation results in sexually dimorphic tissue properties in a physiological tissue-like environment. Therefore, ECT derived from female and male rCF were generated and exposed to E2 or vehicle ( Figure 6 ).
In accordance with the 2D cell culture data, E2-treatment significantly inhibited collagen I and III mRNA levels in female ECT ( Figure 6A ) whereas E2 up-regulated collagen I and III mRNA levels in male ECT ( Figure 6B) . Additionally, we found a significant increase in female ECT volume upon E2-treatment when compared with the vehicle control ( Figure 6C) . In contrast, E2 significantly reduced male ECT volume compared with the control ( Figure 6D) . . Mean ± SEM from 9 to 12 independent samples derived from four independently repeated experiments; **P < _ 0.01, *P < _ 0.05, comparison between treated cells and respective control was performed using Mann-Whitney U-test.
Sex-specific regulation of collagen I and III ER comparison between sexes in non-treated rCF: female: n = 10 and male: n = 12; E2-treatment: from five to six independent samples derived from three independently repeated experiments; **P < _ 0.01 and *P < _ 0.05 comparison was performed using Mann-Whitney U-test. led to no significant change in tissue properties ( Figure 6E and F) . In contrast, E2-treatment of male ECT increased tissue stiffness ( Figure 6G ), which was reflected by a higher Young's modulus ( Figure 6H ). These data suggest that the sex-specific collagen I and III regulation by E2 in ECT is associated with differences in tissue dimensions and biomechanical properties between female and male ECT. This was not due to changes in collagen I to III ratio. In fact, in all models examined, the ratios between both collagens were found to be constant (Supplementary material online, Figure S2 ). To further ensure that E2-induced differences in ECT are not due to changes in cell number or proliferation capacity, we performed total cell count and cell cycle analyses of rCF re-isolated from ECT. Neither in female nor in male ECT a significant E2-effect on cell number or cell cycle could be detected compared with vehicle groups (Supplementary material online, Figure S3 ).
E2 attenuates collagen I and III mRNA in female mouse hearts
Previous studies reported that E2 attenuates collagen deposition in the diseased female mouse heart. 14,15 However, so far it has not been shown whether this is associated with E2-mediated modulation of collagen I and III mRNA level. Therefore, we tested the E2-effect on collagen I and III mRNA in vivo using intact female and OVX mice with and without E2-supplementation that were subjected to 4 weeks of TAC ( Figure 7) . TAC induced collagen I mRNA level in all three groups (intact, OVX, and OVX mice with E2-supplementation) compared with sham operated controls, reaching statistical significance in the OVX mice. Overall, collagen I transcription was the highest in OVX TAC mice, followed by intact TAC (not significant vs. OVX TAC) and OVX E2-supplemented TAC mice (P < _ 0.05 vs. OVX TAC). In the sham operated animals, a similar trend was observed ( Figure 7A) . The up-regulation of collagen III after TAC compared with sham mice showed a similar pattern as observed for collagen I, reaching statistical significance in OVX mice. Collagen III mRNA level was highest in OVX TAC mice, followed by intact (P < 0.05 vs. OVX TAC) and OVX E2-suplemented TAC mice (P < 0.05 vs. OVX TAC). The sham groups showed a similar trend ( Figure 7B ). These data indicate that E2 attenuates cardiac collagen I and III mRNA in female mice under physiological and pathological conditions. Comparisons between all four groups was performed by one-way ANOVA followed by Dunn's multiple comparison test; *P < _ 0.05, **P < _ 0.01, and ***P < _ 0.001.
Sex-specific regulation of collagen I and III 
Discussion
Sex differences in cardiac fibrosis development [4] [5] [6] [7] [8] 10 and the regulatory role of E2 and ER within this process have been reported. 11, [14] [15] [16] 20, 21 However, these studies did not elucidate the underlying molecular mechanisms. We, therefore, aimed to clarify the role of E2 and ER on collagen I and III expression in CF from females and males in more detail. Here, we found that collagen I and III are regulated in a sex-specific manner by E2 in rat and human CF, indicating that this is conserved across species. Data from ECT confirm the sex-dimorphic collagen regulation by E2 in a tissue-like environment. Translational relevance of our results is underscored by the findings in mice, showing that the E2-mediated inhibition of collagen I and III in females also holds true in vivo under physiological and pathological conditions after pressure overload. Further, we identified sex-dimorphic ER-activation and collagen I and III promoter binding as possible underlying mechanisms for the observed distinct transcriptional regulation in female and male CF. Thus, we show that sex differences in cardiac fibrosis development possibly arise from the sex-specific activation of ER by E2, leading to sex differences in collagen I and III gene expression regulation in CF. Altogether, we present novel mechanisms, which help to better understand observed sex differences in cardiac fibrosis, and in the future, this might serve to design pharmacological interventions according to the sex of patients.
E2-mediated sex differences in collagen I and III expression in cardiac fibroblasts
Although the E2-dependent regulation of collagen I and III [26] [27] [28] ). We recently showed that activated ERb plays a role in sexspecific regulation of miR-106a and -106b in rCF. 32 However, in the present study we show that both ER are involved in sex-specific regulation of collagen I and III. Activated ERa is responsible for collagen I and III mRNA down-regulation in female rCF, whereas activated ERb upregulates collagen I and III levels only in male rCF. Thus, we report for the first time an exclusively divergent E2-mediated regulation of collagen I and III mediated by a sex-specific activation of both ER in CF.
Sex differences in ER protein expression levels in cardiac fibroblasts
One possible explanation for sex-dimorphic ER activation by E2 could be that both receptors show significant differences in protein levels between male and female rCF. Different expression levels of ER in hepatocytes from male and females have been shown to underlie E2-mediated Figure 6 Continued between treated ECT and related vehicle control was performed using Mann-Whitney U-test. (E-H) Rheological destructive tensile strength measurements of ECT derived from female and male rCF after 6 days of vehicle or 10 -8 M E2-treatment were performed in an organ bath. from female mice 4 weeks after TAC. Collagen I and III mRNA level were quantified by qPCR and normalized to RPL0. Mean ± SEM from six to nine mice per group. *P < _ 0.05, **P < _ 0.01, one-way ANOVA followed by Tukey's multiple comparison test. Sham, sham operated mice; TAC, transverse aortic constriction; OVX, ovariectomy; placebo, phytoestrogen-free chow and E2-supplementation: 17b-estradiolbenzoate (E2B) in phytoestrogen-free chow.
Sex-specific regulation of collagen I and III sex-specific transcription regulation of the vitellogenein gene. 30 We found no sex-differences in ERa protein level, but higher ERb protein level in female compared with male rCF. E2 significantly down-regulated ERa protein level in female rCF, but up-regulated ERa in male rCF, compared with the vehicle control. There were no changes in ERb protein expression upon E2-treatment in rCF from both sexes. These data suggest that differences in ER protein levels at basal conditions and after E2-treatment between females and males are no possible explanation for the shown sex-specific ER activation in rCF.
Sex differences in ER phosphorylation in cardiac fibroblasts
We considered ER phosphorylation upon E2-treatment as another possible underlying mechanism for sex-specific receptor activation. Posttranslational modifications, such as phosphorylation, are crucial events in ER-activation. 24, 25, 33 Several studies of ERa and ERb have shown that phosphorylation mediates E2-initiated non-genomic signaling and timedelayed genomic actions of these receptors. In particular, phosphorylation at serine 118 and 105 in ERa and ERb respectively, has been reported to alter E2-binding capacity, protein stability, receptor dimerization, subcellular localization, DNA-binding, and interaction with coregulators of both ER. 24, 25 The consequence is an altered gene-specific transcription. In our study, we found that ERa phosphorylation at serine 118 is exclusively activated in female rCF, whereas an increase in ERb phosphorylation at serine 105 only occurred in male rCF in response to E2-treatment. Therefore, we speculate that sex-specific ER phosphorylation underlies E2-mediated sex differences in collagen I and III gene transcription regulation.
The underlying pathways of ER phosphorylation have been shown to be interwoven and to include the activation of several kinases, such as MAPK, PI3k/AKT, Cdk7, and GSK3b. 24, 33 Based on that, we speculate that both ER are targeted by sex-dimorphic kinase signalling in rCF. Interestingly, a much more pronounced E2-dependent increase in MAPK phosphorylation could be detected in female compared with male lung adenocarcinoma cells. 31 Moreover, similar to our study, E2-treatment resulted in an increased phosphorylation of ERa at serine 118 only in female cells, which led to increased cyclin D1 gene transcription only in female lung adenocarcinoma cells. In contrast, as a possible result of E2-mediated ERa phosphorylation, we report a decline in collagen I and III transcription in female rCF. In HeLa cells it was demonstrated that phosphorylation of Ser118-ERa influences transcription in a gene-specific manner, 34 thereby causing an increase, decrease, or no change in transcription. While ERa has been studied well, there is only limited information on E2-mediated phosphorylation of ERb. Data from Lam et al. 33 suggest that E2-mediated phosphorylation at Ser105-ERb is mediated via ERK1/2 and p38-MAPK in human breast cancer cells. How E2-mediated P-Ser105-ERb influences gene expression is not yet clear.
Sex-specific ER binding to collagen I and III promoters in cardiac fibroblasts
Based on the sex-specific activation and E2-mediated differences of ERaand ERb-phosphorylation in male and female rCF, we speculated that sex-dimorphic binding of ER to the collagen I and III promoters in rCF occurs. Indeed, we showed that upon E2-treatment, ERa binds together with ERb to the collagen I and III promoter in female rCF. In male rCF, E2-treatment only induced ERb binding to the collagen I and III promoter. In line with our data, Powell and Xu 35 showed that selectively ac- E2-bound ER homo-and heterodimers interact with a palindromic DNA sequence separated by three nonspecific nucleotides (GGTCAnnnTGACC), the consensus ERE. This is accompanied by the ordered recruitment of a series of coregulators leading to a positively or negatively regulated E2-target gene transcription. 38 Specific ERa and ERb coregulators are known and it has been suggested that they play a significant role in mediating transcriptional differences. 38 Based on these data, we hypothesize that sex-dimorphic ER-binding to the collagen I and III promoter leads to sex-specific recruitment of coregulators ( Figure 8) .
We assume that in female rCF, upon E2-treatment, activated/phosphorylated ERa heterodimerizes with ERb and bind to the collagen I and III promoter. Since it has been shown that ERa is the functional dominant partner in the ER heterodimer 39 this would suggest that ERa dictates regulatory properties in female rCF; that is by co-repressor recruitment.
In contrast, phosphorylation of ERb in male rCF results in ERb homodimerization and collagen promoter binding, followed by co-activator recruitment. In addition, epigenetic modifications at the collagen I and III promoter could be a possible explanation for observed E2 mediated sex differences. It has been reported that upon E2-treatment, ER are involved in epigenetic modifications at the promoter of several ER-target genes. 40, 41 Thereby, E2-activated ER induces gene expression by interacting with a variety of methylases leading to the formation of active modifications (H3K4), by interacting with demethylases leading to removal of repressive histone modifications (H3K9), and by the association with co-activators with histone acetyltransferase activity. E2/ERmediated gene inhibition includes the ER induced removal of H3K4 and formation of H3K9 modifications, recruitment of histone deacetylases and of co-repressors, acting as histone deacetylases. 42, 43 Future studies will clarify which coregulators are recruited by E2-activated ER and whether epigenetic changes at the collagen I and III promoter are responsible for sexually dimorphic regulation of collagen I and III in CF.
Sex-specific role of ER in collagen I and III regulation
The impact of ERa and ERb on cardiac fibrosis development has been reported in mouse models with induced pathological MH. 11, 15, 20, 21, 44 In mice with pressure overload induced MH, ERb deletion attenuated cardiac fibrosis in males compared with WT-controls. 11 
Translational aspect
Under different pathological conditions, men show significantly higher collagen deposition and higher increase in collagen I and III mRNA compared with women. [4] [5] [6] [7] [8] 10 Collagen accumulation adversely influences tissue stiffness, ventricular function and leads to HF progression. Sex differences in the onset and progression of HF have been reported, with males usually showing an earlier transition to HF than females. 13 Postmenopausal women still have significant circulating E2-levels that are approximately the same levels as those of elderly men, synthesized mainly in adipose tissue. 45 This suggests that E2 can act in the hearts of both sexes, even at increased age. Based on that, we speculate that the E2-mediated sex-specific collagen I and III regulation in CF might be one possible explanation for the observed sex differences in cardiac fibrosis and therefore of clinical relevance. Of note, it has been shown that the upstream region of the Col1A1 gene promoter shows a high degree of homology in rats, mice, and humans. [46] [47] [48] This leads to the speculation that the demonstrated binding of ERa and ERb to the ERE within the rat Col1A1 promoter region in this study might be also conserved across these species. Further, ECT data showed E2-mediated sex-specific collagen I and III regulation in a more tissue-like environment. E2-treated female ECT displayed higher volumes, while E2-treated male ECT displayed lower volumes compared with their respective controls. As CF attach to the collagen fibrils within a collagen matrix, spread and migrate, they exert a tractional force leading to the condensation of the tissue. 49 Based on that, we speculate that a reduced collagen synthesis within the female ECT upon E2 leads to a lower tissue condensation. On the other hand, higher collagen secretion by male CF upon E2 leads to higher condensation and more compact male ECT. However, extracellular matrix (ECM) remodelling is a complex process. Other ECM components are also regulated in a sex-specific manner under pathological conditions 5, 6, 10, 12 and can be modulated by E2. 16, 21, 22, 32 Therefore, the regulation of other ECM factors by E2 and their impact on observed sex-dimorphic ECT condensation cannot be excluded and has to be studied in future analysis. ERE ERE Figure 8 Schematic presentation on how E2 and ER modulate collagen I and III in a sex-specific manner in cardiac fibroblasts. In female CF, E2 phosphorylates ERa at serine 118 (P-Ser118), which binds to ERb. Both ER translocate into the nucleus and bind to the identified ERE within the collagen I and III promoter. Recruitment of co-repressor(s) (Co-R) results in down-regulation of collagen I and III gene expression in female cells. In male CF, E2-treatment phosphorylates ERb at serine 105 (P-Ser105), leading to ERb homodimer formation, which then translocates into the nucleus and binds to the identified ERE within the collagen I and III promoter. This is accompanied by co-activator (Co-A) recruitment leading to up-regulation of collagen gene expression in male cells.
Sex-specific regulation of collagen I and III
Conclusions
Sex-specific regulation of collagen I and III expression is mediated via sex-dimorphic ER activation involving differential phosphorylation and promoter binding of ERa and ERb. This regulation is conserved across species and could serve as future target to treat cardiac fibrosis by receptor-specific modulation of collagen expression in CF.
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